Determination of mean values of the number, perimeter and area of CD34-positive of rosacea vessels and evaluation of VEGF expression in skin biopsy specimens of patients with vascular forms.
DOI:
https://doi.org/10.26641/2307-0404.2018.2.133946Keywords:
vascular forms of rosacea, CD34, VEGF, age groupsAbstract
Rosacea is characterized by marked involvement of the central face with transient or persistent erythema formation, telangiectasias, inflammatory papules and pustules and hyperplasia of the connective tissue. The formation of telangiectasia of the surface and intermediate sections of the dermis is an important chain of pathogenesis of vascular forms of rosacea. Modern literature sources allow to attribute this disease to the group of angioproliferative diseases, which are based on the activation of the inflammation and angiogenesis. This leads to the need of studing the mechanisms of vascularization due to growth factors of the vascular components or their receptors in rosacea. The aim of the study was to calculate the mean values of the perimeters and areas of CD34-positive vessels, to evaluate the intensity of expression of the VEGF marker in the skin biopsies of patients with vascular forms of rosacea and to determine the possible dependence of these parameters on the age of the patients. In the work, an immunohistochemical analysis of the material of 11 patients aged 21 to 63 years (mean 40,0±12,49, median 36 years) with a clinical diagnosis of the vascular form of rosacea was performed. Branching, dilatation and induration of the capillary mesh were the typical changes in the dermis in vascular forms of rosacea. which were observed throughout the length of the incisions with an increase in the direction "from the top down", especially around the sebaceous glands and hair follicles. It was established that the mean values of the number, perimeters, and areas of CD34-positive vessels in rosacea biopsy specimens, as well as the levels of VEGF expression, were significantly higher than those of healthy skin (all p<0,05).References
Avtandilov GG. [Medical morphometry: guideline]. Moskva, Meditsima. 1990;384. Russian.
Poslavskaya OV. [Determination of linear dimensions and square square surfaces areas of morphological objects on micrographs using ImageJ software]. Morphologia. 2016;10(3):377-81. Ukrainian.
Poslavska OV. [Methodology for the use of software for the analysis of digital micrographs on the base of pathomorphology course in order to increase the professional level of students and scientists]. Morphologia. 2015;9(3):122-6. Ukrainian.
Cribier B. Pathophysiology of rosacea: redness, telangiectasia, and rosacea. Annales de dermatologie et de venereologie. Elsevier Masson. 2011;138:184-91.
Cribier B. Rosacea under the microscope: characteristic histological findings. Journal of theEuropeanAcademyof Dermatology and Venereology. 2013;27(11):1336-43.
Fowler J, Joseph F. Facial Dermatitis and Rosacea. Semin Cutan Med Surg. 2016;35(6):107-9.
LaversI.Rosacea: clinical features and treatment. Nurs Stand. 2016;30(31):52-59.
Mikkelsen CS, Holmgren HR, Kjellman P, Heidenheim M, Kappinnen A, Bjerring P, Huldt-Nystrøm T. Rosacea: a clinical review. Dermatology reports. 2016;8:6387.
Del Rosso JQ. Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. The Journal of clinical and aesthetic dermatology. 2012;5(3):16-25.
Del Rosso JQ. Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffse and persistent facial erythema of rosacea. The Journal of clinical and aesthetic dermatology. 2012;5(3):26-36
Steinhoff M, Schmelz M, Schauber J. Facial erythema of rosacea-aetiology, different pathophysiologies and treatment options. Acta dermato-venereologica. 2016;96(5):579-89.
Weedon D. Skin pathology, second edition. China, Churchill Livingstone, 2002;1158.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.